Identification of Genetic Factors Determining Disease Course in the New Type of Coronavirus Infection, COVID-19
1 other identifier
observational
1,000
1 country
14
Brief Summary
The study aims to identify environmental factors and genetic (gene mutation and gene expression) changes, which influencing the course of the disease the new type of coronavirus infection COVID-19 in patients nationwide in a multicenter study. At first in the study will be performed 200 patients, selected for a homogeneous groups on the basis of the patient's anamnestic data, genetic testing. Following the interim analysis, based on the results, another 800 people are planned to involve.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2020
14 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 5, 2020
CompletedFirst Submitted
Initial submission to the registry
June 9, 2020
CompletedFirst Posted
Study publicly available on registry
June 11, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2021
CompletedJune 11, 2020
June 1, 2020
7 months
June 9, 2020
June 9, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Identification of genetic factors determining the course of the disease in case of COVID-19
Exploring genotype-phenotype connections based on anamnestic data of patients and joint bioinformatics analysis of its genetic variants
2020. December
Eligibility Criteria
Adults
You may qualify if:
- confirmed covid 19 infection
You may not qualify if:
- informed refusal
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (14)
University of Pécs 1st Department of Internal Medicine Intensive Care Unit
Pécs, Hungary
University of Pécs First Department of Internal Medicine
Pécs, Hungary
University of Pécs Infection Department of the Coronavirus Center
Pécs, Hungary
University of Pécs Institute of Laboratory Medicine
Pécs, Hungary
University of Pécs Szentágotahi Research Centre
Pécs, Hungary
University of Pécs Szentágothai Research Centre Genomics and Bioinformatics Core Facility
Pécs, Hungary
University of Szeged Szentágothai Research Centre Virology Research Group
Pécs, Hungary
University of Szeged Department of Anaesthesiology And Inthensive Therapy
Szeged, 6720, Hungary
University of Szeged Department of Dermatology and Allergology
Szeged, 6720, Hungary
University of Szeged Department of Medical Biology
Szeged, 6720, Hungary
University of Szeged Department of Paediatrics
Szeged, 6720, Hungary
University of Szeged First Department of Medicine
Szeged, 6720, Hungary
University of Szeged Institute of Clinical Microbiology
Szeged, 6720, Hungary
University of Szeged Institute of Medical Microbiology and Immunobiology
Szeged, 6720, Hungary
Related Publications (11)
Danis J, Janovak L, Guban B, Goblos A, Szabo K, Kemeny L, Bata-Csorgo Z, Szell M. Differential Inflammatory-Response Kinetics of Human Keratinocytes upon Cytosolic RNA- and DNA-Fragment Induction. Int J Mol Sci. 2018 Mar 8;19(3):774. doi: 10.3390/ijms19030774.
PMID: 29518010BACKGROUNDChiu RW, Tang NL, Hui DS, Chung GT, Chim SS, Chan KC, Sung YM, Chan LY, Tong YK, Lee WS, Chan PK, Lo YM. ACE2 gene polymorphisms do not affect outcome of severe acute respiratory syndrome. Clin Chem. 2004 Sep;50(9):1683-6. doi: 10.1373/clinchem.2004.035436. No abstract available.
PMID: 15331509BACKGROUNDPinheiro DS, Santos RS, Jardim PCBV, Silva EG, Reis AAS, Pedrino GR, Ulhoa CJ. The combination of ACE I/D and ACE2 G8790A polymorphisms revels susceptibility to hypertension: A genetic association study in Brazilian patients. PLoS One. 2019 Aug 20;14(8):e0221248. doi: 10.1371/journal.pone.0221248. eCollection 2019.
PMID: 31430320BACKGROUNDScepanovic P, Alanio C, Hammer C, Hodel F, Bergstedt J, Patin E, Thorball CW, Chaturvedi N, Charbit B, Abel L, Quintana-Murci L, Duffy D, Albert ML, Fellay J; Milieu Interieur Consortium. Human genetic variants and age are the strongest predictors of humoral immune responses to common pathogens and vaccines. Genome Med. 2018 Jul 27;10(1):59. doi: 10.1186/s13073-018-0568-8.
PMID: 30053915BACKGROUNDDean L. Abacavir Therapy and HLA-B*57:01 Genotype. 2015 Sep 1 [updated 2025 Apr 21]. In: Pratt VM, Scott SA, Pirmohamed M, Esquivel B, Kattman BL, Malheiro AJ, editors. Medical Genetics Summaries [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2012-. Available from http://www.ncbi.nlm.nih.gov/books/NBK315783/
PMID: 28520363BACKGROUNDDanis J, Goblos A, Gal B, Sulak A, Farkas K, Torok D, Varga E, Korom I, Kemeny L, Szell M, Bata-Csorgo Z, Nagy N. Nuclear Factor kappaB Activation in a Type V Pityriasis Rubra Pilaris Patient Harboring Multiple CARD14 Variants. Front Immunol. 2018 Jul 3;9:1564. doi: 10.3389/fimmu.2018.01564. eCollection 2018.
PMID: 30018619BACKGROUNDCao Y, Li L, Feng Z, Wan S, Huang P, Sun X, Wen F, Huang X, Ning G, Wang W. Comparative genetic analysis of the novel coronavirus (2019-nCoV/SARS-CoV-2) receptor ACE2 in different populations. Cell Discov. 2020 Feb 24;6:11. doi: 10.1038/s41421-020-0147-1. eCollection 2020. No abstract available.
PMID: 32133153BACKGROUNDTeng DH, Chen Y, Lian L, Ha PC, Tavtigian SV, Wong AK. Mutation analyses of 268 candidate genes in human tumor cell lines. Genomics. 2001 Jun 15;74(3):352-64. doi: 10.1006/geno.2001.6551.
PMID: 11414763BACKGROUNDPaoloni-Giacobino A, Chen H, Peitsch MC, Rossier C, Antonarakis SE. Cloning of the TMPRSS2 gene, which encodes a novel serine protease with transmembrane, LDLRA, and SRCR domains and maps to 21q22.3. Genomics. 1997 Sep 15;44(3):309-20. doi: 10.1006/geno.1997.4845.
PMID: 9325052BACKGROUNDLin M, Tseng HK, Trejaut JA, Lee HL, Loo JH, Chu CC, Chen PJ, Su YW, Lim KH, Tsai ZU, Lin RY, Lin RS, Huang CH. Association of HLA class I with severe acute respiratory syndrome coronavirus infection. BMC Med Genet. 2003 Sep 12;4:9. doi: 10.1186/1471-2350-4-9.
PMID: 12969506BACKGROUNDManczinger M, Boross G, Kemeny L, Muller V, Lenz TL, Papp B, Pal C. Pathogen diversity drives the evolution of generalist MHC-II alleles in human populations. PLoS Biol. 2019 Jan 31;17(1):e3000131. doi: 10.1371/journal.pbio.3000131. eCollection 2019 Jan.
PMID: 30703088BACKGROUND
Related Links
Biospecimen
Blood, nose and throat swab
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Márta Széll, MD, Ph.D.
University of Szeged, Department of Medical Genetics
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 9, 2020
First Posted
June 11, 2020
Study Start
June 5, 2020
Primary Completion
December 31, 2020
Study Completion
July 31, 2021
Last Updated
June 11, 2020
Record last verified: 2020-06
Data Sharing
- IPD Sharing
- Will not share